A survey on luteal phase support:
|
|
- Derek Sutton
- 5 years ago
- Views:
Transcription
1 A survey on luteal phase support: An IVF Worldwide Survey results I have no conflict of interest!
2 The reason why luteal phase support is needed: The normal physiological support of the corpus luteum the pulsatile secretion of LH by the anterior pituitary is disrupted during controlled ovarian stimulation Mid luteal LH levels ~ 6.0 IU/l in natural cycle (Tavaniotou and Devroey 2003) ~ 1.5 IU/l GnRHa trigger (Humaidan et al. 2005) ~ 0.2 IU/l HCG trigger (Humaidan et al. 2005)
3 The luteal phase after COS Supraphysiological steroid level of E2 and P in early mid luteal phase exerts a negative feed back on the hypothalamic pituitary axis reducing LH secretion in early luteal phase. (Tavaniotou and Devroey, 2006; Tavaniotou et al., 2001) COS per se constitutes an indication for luteal phase support Adapted from Jones 1996 by Fauser and Devroey 2003
4 Pharmacokinetics of hcg administration Weissman et al., Gynecol Endocrinol 10; 273 6: 1996.
5 Figure 1 Chronologic characteristics of the effects of exogenous hcg and hcg produced by the conceptus De Ziegler et al., Fertility and Sterility ,
6 Luteal phase support in ART Formulation and route of administration When to start? When to stop? What should be included? Should LPS in ART be individualized?
7 Evidence Based Medicine
8 Type of reporting bias Publication bias Time lag bias Multiple (duplicate) publication bias Location bias Citation bias Language bias Outcome reporting bias Definition The publication or non publication of research findings, depending on the nature and direction of the results The rapid or delayed publication of research findings, depending on the nature and direction of the results The multiple or singular publication of research findings, depending on the nature and direction of the results The publication of research findings in journals with different ease of access or levels of indexing in standard databases, depending on the nature and direction of results. The citation or non citation of research findings, depending on the nature and direction of the results The publication of research findings in a particular language, depending on the nature and direction of the results The selective reporting of some outcomes but not others, depending on the nature and direction of the results Jonathan AC Sterne, Matthias Egger and David Moher on behalf of the Cochrane Bias Methods Group, 2011.
9 Ties with the industry: 87% of authors have ties to industry 58% receive financial support for research 38% serves as employs or consultants Roger Collier, CMAJ, 2011:183;3
10
11 Focus on professional education Surveys Blogs / Forums Genetics Virtual Academy Physicians consulting physicians Newsletters Online Journal Education Center Clinic Locator IVF Worldwide Online Informed Consent Virtual university
12 IVF Worldwide surveys Large number of units (over 3,800) All 6 continents Data from academic and non academic practices A global scale
13 The Wisdom of the Crowds James Surowiecki 2004 Why the many are smarter than the few and how collective wisdom shapes business, economies, societies and nations
14 Anti Mullerian hormone (AMH) and antral follicular count (AFC) The Surveys Minimising the risk of infection and bleeding at trans vaginal ultrasound guided ovum pick up Vitrification, GnRH trigger and differed ET Mechanical Infertility Oocyte Donation Reproductive Immunology Practice in IVF Embryo Culture and Catheter Loading Egg Collection and Embryo Transfer Techniques PCOS Definition, Diagnosis and Treatment Poor Responders The use of GnRH agonist in IVF protocols Metformin Use In IVF Patients Frozen Thawed Embryo Transfer Updated survey on the use of progesterone for luteal phase support in stimulated IVF cycles Progesterone Support In IVF
15 1 st nd 2012
16 Geographic distribution of IVF units participating in the survey Continent IVF Cycles % of cycles IVF units % of IVF units USA & Canada South America Australia & New Zealand Asia Europe Africa Total
17 % Which factor is most important to you when deciding which luteal support regimen to use?
18 % In most cases, how do you determine which luteal support regimen to use for your patients?
19 If you support the luteal phase, when do you start the regimen you use? At the time of hcg admin. At the time OPU One day post OPU At the time of ET 6 days post OPU
20 Figure 1 Chronologic characteristics of the effects of exogenous hcg and hcg produced by the conceptus De Ziegler et al., Fertility and Sterility ,
21 LBR (%) mg micronized progesterone Vaginally b.i.d
22 RCT
23 RCT LPS: Uterogestan 400 mg/d Group A: from the evening of the day of oocyte retrieval Group B: from the evening of embryo transfer (2nd day).
24 RCT LPS: Micronized progesterone (3 200 mg); 2 mg of estradiol valerate p.o. ; 20 mg of dydrogesterone Group A: from the first day after oocyte retrieval (n = 526) Group B: From day 4 after oocyte retrieval (n = 527).
25 RCT LPS: Prometrium, 200 mg intravaginally t.i.d. Group A: from the morning of the 3rd day after oocyte retrieval Group B: from the morning of the 6th day after oocyte retrieval
26 When to start LPS? Day of OPU Day after OPU Day of ET All equally effective Initiating LPS on the day of or day after oocyte retrieval, has now become a routine practice in ART
27 % If you support the luteal phase, when do you start the regimen you use?
28 How long do you continue progesterone supplementation if the patient conceives? At the time of pregnancy test At the time of 1 st US (6W) At 8 W At W
29
30 Ongoing pregnancy rate
31 Ongoing pregnancy rate
32 Live birth rate
33 Miscarriage rate
34 When to stop LPS? Day of positive hcg Day fetal heartbeat Week All have similar ongoing pregnancy rates On the day of the positive hcg the CL is supported by hcg of embryonic origin Clinical data now confirm this view This should encourage treatment teams to discontinue LPS on the day of positive hcg
35 % How long do you continue progesterone supplementation if the patient conceives?
36 How long do you continue progesterone supplementation if the patient conceives? Positive bhcg Clinical preg Week
37 % In the majority of the cases, which agent/route is your treatment of choice for LPS?
38 Vaginal P for luteal support: Targeted drug delivery One hour after application Four hours after application Progressive diffusion of progesterone from the cervix to the fundus of the uterus Bulletti et al. Hum Reprod. 1997;12:1073-9
39 Steady State Serum vs Tissue Levels of Progesterone Serum P ng/ml Tissue ng/mg protein Crinone 8% IMP Cicinelli et al. Obstet Gynecol 2000;95:403-6
40 % If you use vaginal progesterone, which formulation do you prefer to use in the majority of cases?
41
42 Child et al., RBM Online, in press
43 % If you use oral progesterone, which drug do you prefer?
44 Oral Micronized Progesterone
45 Progesterone for luteal support: the oral route Micronization: improved absorption of oral P Poor bioavailability Circulating levels are too low for adequate support Liver first pass leads to massive metabolism At best 10% circulates as active P Inadequate secretory transformation Dose increase: unacceptable somnolence Nahoul and de Ziegler D. Fertil Steril 1994;61: Bourgain et al., Hum Reprod 1990;5:
46 Serum levels of P after oral vs. vaginal administration (RIA and liqiud chromatography mass spectrometry) Levine et al., Fertil Steril Vag - true Vag - RIA Oral - true Oral - RIA Crinone 90mg vaginally vs Prometrium 100mg orally
47 Outcome with oral P administration 70 Licciardi et al Friedler et al * * 0 CPR IR IM P PO P * P< CPR IR Miscarriage Vag P PO P
48 Oral dydrogesterone
49 Oral dydrogesterone for luteal phase support in IVF An oral retroprogesterone progesterone agonist Approved for: Threatened and recurrent miscarriage (associated with proven progesterone deficiency) Infertility due to luteal phase insufficiency It has been extensively used for a variety of indications since 1960 Compared with progesterone: Greater affinity for the progesterone receptors Can be used at lower oral doses to promote endometrial proliferation owing to its better bioavailability and to the progestogenic activity of its metabolites Schindler AE et al., Maturitas 2008;61:
50 Barbosa Et al., Ultrasound Obstet Gynecol 2016; 48:
51 RCT LPS: From the day of oocyte retrieval Group A: MVP 200 mg capsules TID with oral placebo tablets TID Group B: Oral dydrogesterone 10 mg tablets TID with placebo intravaginal capsules TID
52 Ongoing pregnancy rates and live birth rates in the (total n = 974) LOTUS I trial. Fertility and Sterility , DOI: ( /j.fertnstert )
53 Proportion of female subjects reporting treatment emerging adverse events according to organ system in the two groups of the LOTUS I trial. Fertility and Sterility , DOI: ( /j.fertnstert )
54 Noninferiority of daily 30 mg oral dydrogesterone for luteal phase support Well tolerated as vaginal progesterone in safety analyses No new fetal safety concerns Widespread preference of women for an oral compound Dydrogesterone may well become the new standard for LPS in fresh IVF ET cycles
55 IM Progesterone
56 Progesterone for luteal support: The intramuscular route P is highly water insoluble P in oil Standard route of P delivery High efficiency: avoids hepatic first pass Several drawbacks: *Painful and uncomfortable * Preservatives (benzyl alcohol) *Sterile abscess formation *Allergic response *Time and cost
57 Progesterone for luteal support: The intramuscular route IM dosing: mg daily Long acting formulations Mean production rate of progesterone of 25 mg/24 h Gold standard of LPS in phase endometrial architecture Satisfactory pregnancy/miscarriage rates Able to delay menses in most women
58 Progesterone regimens: IM versus vaginal/rectal: Live birth and ongoing pregnancy rates OR 1.37, 95% CI 0.94 to 1.99 seven RCTs, 2309 women, I2 = 71%, random effects, very low quality evidence Live birth rate, no evidence suggested differences between groups OR 1.31, 95%CI 0.84 to 2.05 four RCTs, 1222 women, I2 = 59%, random effects model Van der Linden et al., Cochrane Database of Systematic Reviews 7 JUL 2015
59 % If you use IM progesterone, which interval/formulation do you prefer?
60 SC Progesterone
61 Aqueous subcutaneous progesterone Water insolubility of P: an aqueous preparation of P was seemingly impossible Enhancing polarity by encapsulation of P molecules in a starch residue, cyclodextrine On reaching bodily fluids, cyclodextrine is readily digested This liberates native P, which reaches the general circulation Prolutex is available in single use preparations Contains no preservatives de Ziegler et al., Fertil Steril 2013
62 Non inferiority of SC P versus vaginal P Ongoing PR (10 wks) (%) Live birth rate (%) Prolutex Crinone 95% CI Lockwood et al. Fertil Steril 2013 Prolutex Endometrin 95% CI Ongoing PR (10 wks) (%) Live birth rate (%) Baker VL et al. Hum Reprod 2014 Prolutex vs. Vag P (n=1435) Ongoing PR (10 wks) (%) Live birth rate (%) OR % CI Doblinger et al. Plos One 2016
63 % If you use a combination of progesterone treatments, which do you prefer?
64 Do you include estradiol in your luteal support regimen?
65 Normal menstrual cycle
66 Figure 1 Chronologic characteristics of the effects of exogenous hcg and hcg produced by the conceptus De Ziegler et al., Fertility and Sterility ,
67 RCT Patients with E2 >2500 pg/ml on hcg day LPS: IM + Vag P Group A: 2 mg of E2 (Estrofem) p.o. b.i.d. starting on day 7 after ET (n=136) Group B: P only (n=149)
68 Luteal phase estradiol supplementation * CPR IR Miscarriage * P<0.05 P only P+E Farhi et al. Fertil Steril 2000
69 RCT Patients <40 years on long GnRH a protocol LPS: Uterogestan 200 mg t.i.d from opu day Group A: Uterogestan only Group B: Uterogestan + 2 mg E2 Group B: Uterogestan + 6 mg E2
70 4 Progesterone vs progesterone + oestrogen, outcome: 4.1 Live birth/ongoing pregnancy rate. Van der Linden et al., Cochrane Database of Systematic Reviews 7 JUL 2015
71 % Do you include estradiol in your luteal support regimen?
72 When triggering ovulation with a GnRH agonist, which luteal support do you use?
73 GnRH agonist trigger Individualized luteal support regimen Intensive luteal support Adjuvant low dose hcg o o o Dual trigger with hcg (range 1, IU) Adjuvant hcg at time of oocyte retrieval Micro hcg doses Recombinant LH GnRH agonists Freeze all
74 Mid luteal LH levels ~ 6.0 IU/l in natural cycle ~ 1.5 IU/l GnRHa trigger ~ 0.2 IU/l HCG trigger
75 F.C.H. personal DATA (7/ /2017) n=647 Age Group: <= >= 40 Age 28,38 ±1,77 (48) 33,37 ±1,37 (178) 37,80 ±1,09 (220) 41,88 ±1,93 (201) Mean Nr. Cycles 1,60 ±1,18 (48) 2,22 ±1,81 (178) 2,71 ±2,62 (220) 3,46 ±2,73 (201) BMI 24,54 ±4,01 (46) 23,74 ±4,43 (178) 23,17 ±3,63 (220) 22,60 ±3,24 (201) Cycles Freeze All (FA) 10 (20,8%) 38 (21,6%) 20 (9,2%) 12 (6,0%) PBGT 10 (20,8%) (3) 50 (28,4%) (18) 129 (59,4%) (47) 169 (84,5%) (33) (nr.pregnant) ETs (%/without FA) 33 (86,8%) 128 (92,8%) 173 (87,8%) 108 (57,4%) CPR (%/ET) 19 (59%) 82 (64,1%) 87 (50,3%) 40 (37%) Twin(%/Pregnancy ) 5 (26,3%) 28+1 (35,4%) 25 (28,7%) 4 (10,0%) Clinical Misscar. 1 (5,3%) 13 (14,6%) 14 (14,9%) 12 (30,0%) Ongoing/LBR 18 (48,7%) 69 (50,0%) 73 (37,1%) 28 (14,9%) OHSS (E+L) Total pos hcg/et 22 (66,7%) 90 (70,3%) 96 (55,5%) 48 (44,4%) Bioch.Preg I.R. 43,6% 51,6% 40,1% 29,7%
76 46 patients at risk for OHSS GnRH a trigger Nafarein (Synarel) 200 g*2 daily from the evening of OPU No other form of luteal support Fertil Steril, 2016
77 % When triggering ovulation with a GnRH agonist, which luteal support do you use?
78 % If all progesterone formulations were found to yield the same live birth rates, which route would?
79 Evolution of luteal support policies across the years First study (September 2009) Second study (June 2012) Current study (2018) Use of vaginal progesterone only (%) Use of IM progesterone only (%) Use of Oral progesterone only Use of combined drugs Use of hcg only worldwide.com/survey/a survey on luteal phase progesterone support.html
80 % Are more studies needed to reach a decision on the efficacy of the various luteal phase support?
81 % I would like to see more research data about the following routes/formulations:
82 Team
83 Amount of information generated by meta analyses. PubMed search of the words meta analysis in the published literature. Greco et al., Heart Lung Vessel. 2013; 5):
84 Van der Linden et al., Cochrane Database of Systematic Reviews 7 JUL 2015
LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationEndometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY
Endometrial Preparation for Frozen Embryo Transfer (FET) Zitao Liu, MD, PhD New Hope Fertility Center, NY Natural Cycle FET Protocol for endometrial preparation N FET, including modified N FET HRT FET:
More informationResults of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS
Results of the Virtual Academy of Genetics (VAoGEN) questionnaire on Mosaicism in PGS Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationData collected through IVF- Worldwide.com
Data collected through IVF- Worldwide.com Science vs. Clinical Practice Zeev Shoham, MD Director of the Reproductive Medicine and IVF Unit Department Ob/Gyn, Kaplan Medical Center Rehovot, Israel 1 Evidence
More informationDisclosure. Robert Fischer Fertility Centre Hamburg Hamburg, Germany. Declared no potential conflict of interest.
Disclosure Robert Fischer Fertility Centre Hamburg Hamburg, Germany Declared no potential conflict of interest. Updates on Luteal Phase supplementation Kiev 21.09.2018 Robert Fischer MVZ Fertility Center
More informationHow to make the best use of the natural cycle for frozen-thawed embryo transfer?
How to make the best use of the natural cycle for frozen-thawed embryo transfer? Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationEmbryo transfer and Luteal phase support
Embryo transfer and Luteal phase support PATCHARADA AMATYAKUL, M.D. DEPARTMENT OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE NARESUAN UNIVERSITY Embryo Transfer http://www.regionalfertilityprogram.ca/program-embryotransfer.php
More informationHow do we choose the best progesterone to support the luteal phase
How do we choose the best progesterone to support the luteal phase Prof. Dr. Herman Tournaye MSD Fertility Regional Stand Alone Scientific Symposium Lisbon In the last 3 years the speaker or the speaker
More informationHow to make the best use of the natural cycle for frozen-thawed embryo transfer?
How to make the best use of the natural cycle for frozen-thawed embryo transfer? Ariel Weissman, MD IVF Unit, Dep. Ob/Gyn Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationNuoveprospettive per la faseluteale.
Nuoveprospettive per la faseluteale. Dr. Ilario Candeloro Centro di Procreazione Medicalmente Assistita ASST Papa Giovanni XXIII Bergamo The role of LH and progesterone in the luteal phase Totally responsible
More informationPoor & Hyper responders: what is the best approach?
Poor & Hyper responders: what is the best approach? A. La Marca ObGyn Dept University of Modena and Reggio Emilia Italy Center for Reproductive Medicine University Hospital of Modena Italy Criteria used
More informationEvaluation of an optimal luteal phase support protocol in IVF
Acta Obstet Gynecol Scand 2001; 80: 452 466 Copyright C Acta Obstet Gynecol Scand 2001 Printed in Denmark All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE
More informationestrogen supplementation for luteal phase support.
Rationale and regimens of progesterone and estrogen supplementation for luteal phase support. Cicinelli E. IV Dept. Ob/Gyn, University of Bari, Italy cicinelli@gynecology1.uniba.it Luteal phase defect
More informationSTIMULATION AND OVULATION TRIGGERING
STIMULATION AND OVULATION TRIGGERING Professor IOANNIS E. MESSINIS MD, PhD (Aberdeen, UK), FRCOG (UK) Department of Obs/Gynae University of Thessaly Larissa, GREECE DISCLOSURE Nothing to disclose Learning
More informationOvarian hyperstimulation syndrome (OHSS)
Ovarian hyperstimulation syndrome (OHSS) OHSS OHSS: exaggerated response to gonadotropins and hcg Characterized by: ovarian enlargement increased vascular permeability fluid accumulation in abdomen Associated
More informationUniversal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.
Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006
More informationIntérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium
Intérêt de l hcg et induction de l ovulation Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium Conflict of interest The opinions expressed in this document are the opinions
More informationProgesterone and clinical outcomes
Synchronization of Slowly Developing Embryos Restores Implantation Success Richard T. Scott, Jr, MD, HCLD Clinical and Scientific Director, Reproductive Medicine Associates of New Jersey Professor and
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationLuteal phase support (LPS): dose ranging issues and new perspectives
Charlers Chapron Bruno Borghese Hervé Foulot Amin Bititi Paul Mazurk Guillaume Pierre Marie Christine Lafay Fouzia Decupere François X. Aubriot Dominique de Ziegler Vanessa Gayet Pietro Santulli Rebecca
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 72, NO. 5, NOVEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationProgesterone support of the luteal phase and in the first trimester
Progesterone support of the luteal phase and in the first trimester This statement has been developed and reviewed by the Women s Health Committee and approved by the RANZCOG Board and Council. A list
More informationRaoul Orvieto. The Chaim Sheba Medical Center Tel Hashomer, Israel. Declared no potential conflict of interest
Raoul Orvieto The Chaim Sheba Medical Center Tel Hashomer, Israel Declared no potential conflict of interest LH in antagonist cycles; is the story really written? Raoul Orvieto M.D. Israel Overview Role
More informationThrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology
Thrombosis during assisted reproduction Scott Nelson Muirhead Chair in Obstetrics & Gynaecology ART can be as safe as natural pregnancy!! What used to be the risk of thrombosis in ART!! We can use AMH
More informationLH activity administration during the
LH activity administration during the luteal-follicular transition Richard Fleming On behalf of the Luveris Pre-treatment group University of Glasgow Scotland Androgens have a Paracrine action in the Early
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationMinimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology
Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication
More informationLuteal phase support
FERTILITY AND STERILITY VOL. 77, NO. 2, FEBRUARY 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Luteal phase support
More informationDr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management
Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationMatched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer
Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer Naveed Khan, M.D., a Kevin S. Richter, Ph.D., a Tasha L.
More informationIn vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day of HCG injection: An RCT
Int J Reprod BioMed Vol. 15. No. 12. pp: 757-762, December 2017 Original article In vitro fertilization outcome in frozen versus fresh embryo transfer in women with elevated progesterone level on the day
More informationArticle Vaginal gel versus intramuscular progesterone for luteal phase supplementation: a prospective randomized trial
RBMOnline - Vol 16. No 3. 2008 361-367 Reproductive BioMedicine Online; www.rbmonline.com/article/3193 on web 21 January 2008 Article Vaginal gel versus intramuscular progesterone for luteal phase supplementation:
More informationSample size a Main finding b Main limitations
1 Table 1. Available studies on the relation between endometriosis and miscarriage (1995-2015). Study (citation) Country Study period Study design Sample size a Main finding b Main limitations Matoras
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationprogesterone 100mg vaginal tablets (Lutigest ) SMC No. (1185/16) Ferring Pharmaceuticals Ltd
progesterone 100mg vaginal tablets (Lutigest ) SMC No. (1185/16) Ferring Pharmaceuticals Ltd 09 September 2016 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product
More informationIVF Protocols: Hyper & Hypo-Responders, Implantation
IVF Protocols: Hyper & Hypo-Responders, Implantation Midwest Reproductive Symposium June 4-5, 4 2010 Subset : Hyper-Responders Mark R. Bush, MD, FACOG, FACS OBJECTIVE: Important goals for the PCOS patient
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationVaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,
More informationENDOCRINE CHARACTERISTICS OF ART CYCLES
ENDOCRINE CHARACTERISTICS OF ART CYCLES DOÇ. DR. SEBİHA ÖZDEMİR ÖZKAN KOCAELI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, IVF UNIT 30.04.2014, ANTALYA INTRODUCTION The endocrine
More informationUse of in vitro maturation for fertility preservation
Use of in vitro maturation for fertility preservation G. Arroyo Servei de Medicina de la Reproducció Departament d Obstetrícia, Ginecologia i Reproducció INSTITUT UNIVERSITARI DEXEUS MEDICAL STRATEGY TO
More informationProgesterone Vaginal Ring for Luteal Support
The Journal of Obstetrics and Gynecology of India (January February 2015) 65(1):5 10 DOI 10.1007/s13224-014-0634-0 INVITED REVIEW ARTICLE Progesterone Vaginal Ring for Luteal Support Stadtmauer Laurel
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationDr. Madhuri Patil. M.D., DGO, FCPS, DFP, FICOG. (Mum) Dr. Patil s Fertility & Endoscopy Clinic Bangalore
OHSS Have we found a solution? Dr. Madhuri Patil M.D., DGO, FCPS, DFP, FICOG. (Mum) Dr. Patil s Fertility & Endoscopy Clinic Bangalore Ovarian hyperstimulation syndrome Serious and detrimental complication
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationLuteal Phase Support in In Vitro Fertilization
118 Luteal Phase Support in In Vitro Fertilization Elena H. Yanushpolsky, MD 1 1 Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Semin
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Human Ovarian Steroidogenesis and Gonadotrophin Stimulation Johan
More informationA rationale for timing of luteal support post GnRH agonist trigger. Address: IVF Unit, Elisha Hospital, 12 Yair Katz Street, Haifa, Israel,
Short Review: A rationale for timing of luteal support post GnRH agonist trigger Shahar Kol, IVF Unit, Elisha Hospital, Haifa, Israel. Address: IVF Unit, Elisha Hospital, 12 Yair Katz Street, Haifa, Israel,
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationNo influence of the indication of freeze-all strategy on subsequent outcome to frozen-thawed embryo transfer cycle
Original paper No influence of the indication of freeze-all strategy on subsequent outcome to frozen-thawed embryo transfer cycle T. Masschaele 1,2, F. VandekerckhoVe 2, P. de sutter 2, J. Gerris 2 1 AZ
More informationThe effect of luteal phase progesterone supplementation on natural frozen-thawed embryo transfer cycles
Original Article Obstet Gynecol Sci 2014;57(4):291-296 http://dx.doi.org/10.5468/ogs.2014.57.4.291 pissn 2287-8572 eissn 2287-8580 The effect of luteal phase progesterone supplementation on natural frozen-thawed
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationArticle Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
RBMOnline - Vol 13. No 3. 2006 326 330 Reproductive BioMedicine Online; www.rbmonline.com/article/1911 on web 13 June 2006 Article Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150
More informationDisclosure. Lyubov Mykhaylshyn IVF department Alternativa clinic Lviv, Ukraine
Disclosure Lyubov Mykhaylshyn IVF department Alternativa clinic Lviv, Ukraine I do not currently have, nor have I had in the 12 months preceding the activity, a vested interest or affiliation with any
More informationL2. Optimising IVF outcomes through increased number of oocytes... 03
SCIENTIFIC HIGHLIGHTS EXCEMED Blended Education Ovarian stimulation strategies: maximizing efficiency in ART Rio de Janeiro, Brazil 6-7 April 2018 Preface Success rates following IVF treatment have increased
More informationAre all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?
Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial
More informationAdvanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy
Advanced age, poor responders and the role of LH supplementation C. Alviggi University Federico II, Naples, Italy LH serum level (IU/L) 20.0 15.0 10.0 5.0 0.0 LH levels during spontaneous and stimulated
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationPresident : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman ICOG. Founder Trustee Women s Empowerment Foundation
Founder President: The PCOS Society, India Honorary Fellow of the Royal College of Obst.& Gyn. Prof.Duru Shah President : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman
More informationWhat is the POSEIDON concept?
Improving Success in ART: how to define it and key strategies to get the best outcomes, Kiev, 21-09-2018 What is the POSEIDON concept? Alessandro Conforti Italy Objectives Unravel the definition of POR
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationNGUYEN QUOC ANH. M.D., M.Sc. Tu Du Hospital Vietnam
NGUYEN QUOC ANH M.D., M.Sc. Tu Du Hospital Vietnam FULLY AUTOMATED AMH TESTING OF OVARIAN RESPONSE IN IVF NGUYỄN QUỐC ANH MD. Infertility dep. Tudu hospital Index What is AMH? Standard AMH testing Fully
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationScientific Highlights: First world conference on luteinizing hormone in ART: Landing in Asia Pacific
This EXCEMED conference followed on from the First world conference on luteinizing hormone (LH) in ART, which took place in Naples in May 2016. Bringing the topic of LH to Asia Pacific provided an opportunity
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More information% Oocyte Donation Pregnancyes (days 3)
Ovulation induction in oocyte donors Roma- September 2007 Dr. José Remohí Dr. Carmen Rubio Dr. Amparo Mercader Dr. Pilar Alama Dr. Marco Melo Evolution of oocyte donation cycles 1500 1500 1000 58% 661
More informationR-Recent Advance in Patient Friendly Protocol
R-Recent Advance in Patient Friendly Protocol Somjate Manipalviratn, M.D. Reproductive Endocrinologist and Infertility Specialist Clinical Director Superior A.R.T., Bangkok, Thailand Objective of ovarian
More informationPreventing ovarian hyperstimulation syndrome: guidance for the clinician
MODERN TRENDS Edward E. Wallach, M.D. Associate Editor Preventing ovarian hyperstimulation syndrome: guidance for the clinician Peter Humaidan, M.D., a Jens Quartarolo, M.D., b and Evangelos G. Papanikolaou,
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationDipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche. Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare
Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare Carlo Alviggi The rational of Follicular synchronization
More informationDuration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial
Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial Christine S. Goudge, M.D., Theodore C. Nagel, M.D., and Mark A. Damario, M.D. Division
More informationDr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationPuberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1
Puberty and Fertility Jennifer Badik*, MD Pediatric Endocrinology and Jessica Spencer*, MD, MSc Reproductive Endocrinology and Infertility Part One PUBERTY! *no conflicts of interest to report Every girl
More informationPituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.
UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.
More informationOrgalutran 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 1. NAME OF THE MEDICINAL PRODUCT 0.25 mg/0.5 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains 0.25 mg of ganirelix (INN) in 0.5 mg aqueous solution.
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationSpontaneous ovulation versus HCG triggering for timing natural-cycle frozen thawed embryo transfer: a randomized study
Reproductive BioMedicine Online (2011) 23, 484 489 www.sciencedirect.com www.rbmonline.com ARTICLE Spontaneous ovulation versus HCG triggering for timing natural-cycle frozen thawed embryo transfer: a
More informationERA. Endometrial Receptivity Analysis. Patented since
Endometrial Receptivity Analysis Patented since 2009 www.igenomix.com ERA ERA analyzes by NGS the expression of 236 genes in order to determine the personalized window of implantation for each patient.
More information